eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2008
vol. 12
 
Share:
Share:
more
 
 
abstract:

Cancer related cachexia management – blessing for patients and curse for the National Health Fund? A critical analysis of cachexia treatment in Poland

Krzysztof Krzemieniecki

Współczesna Onkologia (2008) vol. 12; 1 (38–42)
Online publish date: 2008/03/20
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Cancer anorexia/cachexia syndrome (CAC) is found in almost two thirds of all cancer patients in the course of their disease. Worse clinical status and decrease in the quality of life in this subset of patients are the most common consequences of cachexia. Nutritional disorders can be responsible for anticancer treatment discontinuation in many patients with potentially treatable disease. The modern treatment modalities for CAC syndrome and number of patients suitable for such treatment generate high reimbursement costs. Are there any strong rationales to use megestrol acetate in all cachectic patients? The most clinically accurate selection criteria for CAC syndrome therapy and its timing as well as use of other strategies improving patients’ nutrition can lead to validation of local guidelines for management of this important clinical issue.
keywords:

cancer anorexia/cachexia syndrome, megestrol acetate, reimbursement

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe